Cost-effectiveness of Canakinumab for Prevention of Recurrent Cardiovascular Events
Sign Up to like & getrecommendations! Published in 2019 at "JAMA Cardiology"
DOI: 10.1001/jamacardio.2018.4566
Abstract: Importance In the Canakinumab Anti-inflammatory Thrombosis Outcome Study (CANTOS) trial, the anti-inflammatory monoclonal antibody canakinumab significantly reduced the risk of recurrent cardiovascular events in patients with previous myocardial infarction (MI) and high-sensitivity C-reactive protein (hs-CRP)… read more here.
Keywords: cost effectiveness; recurrent cardiovascular; canakinumab; cardiovascular events ... See more keywords
Cost-effectiveness of Response-Adapted De-escalation of Immunotherapy in Advanced Melanoma.
Sign Up to like & getrecommendations! Published in 2022 at "JAMA dermatology"
DOI: 10.1001/jamadermatol.2022.4556
Abstract: Importance Combination immunotherapy with nivolumab and ipilimumab has markedly improved outcomes for patients with advanced melanoma. However, these therapies pose a considerable financial burden to both patients and the health care system. The ADAPT-IT trial… read more here.
Keywords: advanced melanoma; cost; response adapted; response ... See more keywords
Cost-Effectiveness Analysis of 3D Total-Body Photography for People at High Risk of Melanoma.
Sign Up to like & getrecommendations! Published in 2025 at "JAMA dermatology"
DOI: 10.1001/jamadermatol.2025.0219
Abstract: Importance Greater use of novel digital technologies could be associated with improved health outcomes and save health care costs by detecting smaller melanomas earlier (needing less treatment) or benign tumors (needing no treatment). Objective To… read more here.
Keywords: care; melanoma; high risk; cost ... See more keywords
Cost-effectiveness of the Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults
Sign Up to like & getrecommendations! Published in 2018 at "JAMA Internal Medicine"
DOI: 10.1001/jamainternmed.2017.7431
Abstract: Importance The live attenuated herpes zoster vaccine (ZVL) is recommended for immunocompetent adults 60 years or older, but the efficacy wanes with age and over time. A new adjuvanted herpes zoster subunit vaccine (HZ/su) has… read more here.
Keywords: cost; herpes zoster; price; dose ... See more keywords
Cost-effectiveness of Empagliflozin in Patients With Heart Failure With Preserved Ejection Fraction.
Sign Up to like & getrecommendations! Published in 2022 at "JAMA internal medicine"
DOI: 10.1001/jamainternmed.2022.5010
Abstract: Importance In the Empagliflozin Outcome Trial in Patients With Chronic Heart Failure With Preserved Ejection Fraction (EMPEROR-Preserved), empagliflozin significantly reduced hospitalizations for heart failure while improving patient-reported health status compared with placebo. The long-term cost-effectiveness… read more here.
Keywords: heart failure; cost effectiveness; heart;
Cost-effectiveness Analysis of Genetic Testing and Tailored First-Line Therapy for Patients With Metastatic Gastrointestinal Stromal Tumors
Sign Up to like & getrecommendations! Published in 2020 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2020.13565
Abstract: Key Points Question Is targeted gene testing cost-effective in patients with metastatic gastrointestinal stromal tumor? Findings This economic evaluation developed a Markov model to examine the cost-effectiveness of targeted gene testing with tailored imatinib dosing… read more here.
Keywords: metastatic gastrointestinal; patients metastatic; gastrointestinal stromal; testing tailored ... See more keywords
Cost-Effectiveness of Neoadjuvant-Adjuvant Treatment Strategies for Women With ERBB2 (HER2)–Positive Breast Cancer
Sign Up to like & getrecommendations! Published in 2020 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2020.27074
Abstract: This economic evaluation modeled the cost-effectiveness of 5 neoadjuvant-adjuvant treatment strategies for women with ERBB2-positive breast cancer. read more here.
Keywords: effectiveness neoadjuvant; neoadjuvant adjuvant; adjuvant treatment; treatment strategies ... See more keywords
Evaluation of the Cost-effectiveness of Services for Schizophrenia in the UK Across the Entire Care Pathway in a Single Whole-Disease Model
Sign Up to like & getrecommendations! Published in 2020 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2020.5888
Abstract: Key Points Question Which interventions are cost-effective for the prevention and treatment of schizophrenia? Findings In this decision analytical model using a simulated cohort of 200 000 individuals, the following interventions were found to be cost-effective:… read more here.
Keywords: evaluation cost; effectiveness services; model; cost effective ... See more keywords
Availability of Cost-effectiveness Studies for Drugs With High Medicare Part D Expenditures
Sign Up to like & getrecommendations! Published in 2021 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2021.13969
Abstract: This cross-sectional study examines the availability and quality of published cost-effectiveness studies for drugs with the greatest Medicare Part D spending in 2016. read more here.
Keywords: availability; medicare part; studies drugs; cost effectiveness ... See more keywords
Cost-effectiveness of Low-Dose Computed Tomography With a Plasma-Based Biomarker for Lung Cancer Screening in China
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.13634
Abstract: This economic evaluation compares the cost-effectiveness of lung cancer screening strategies using low-dose computed tomography (LDCT) and a plasma-based biomarker or LDCT alone in a simulated population of Chinese adults with a history of smoking. read more here.
Keywords: lung cancer; computed tomography; dose computed; cancer screening ... See more keywords
Appraising Drugs Based on Cost-effectiveness and Severity of Disease in Norwegian Drug Coverage Decisions
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.19503
Abstract: This cross-sectional study evaluates a systematic drug appraisal method that uses severity of disease to account for a fair distribution of health in cost-effectiveness analysis. read more here.
Keywords: drug; severity disease; cost effectiveness;